1Hess LM, Jeter JM, Benham-Hutchins M, et al. Factors associated with osteonecrosis of the jaw among bisphos- phonate users [J]. Am J Med,2008,121(6) :475-483.
2Kyrgidis A,Barbas A. Osteonecrosis of the jaw among bisphosphonate users[J]. Am J Med, 2008,121 (12) : e21.
3Fleiseh H, Graham R, Russell G, et al. DI Phos Phonates inhibit hydroxyapatite dissolution and bone resorption in tissue culture and in vivo[J]. Science, 1969,165 ( 3899 ) :1262-1264.
4Fleiseh H. Experimenial basis for the clinical use of diPhosPhonates in Paget's disease of bone[J]. Arthritis Rheum,1980,10(23) :1162-1171.
5Ebetino FH, Francis MD, Rogers MJ, et al. Etidronate mechanism of action of etidronate and other bisphosphonates[J]. Rev Contemp Pharmacol,1998,9(5) :233-243.
6Gutta R, Louis PJ. Bisphosphonates and osteonecrosis of the jaws: science and rationale[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2007,2(104): 186-193.
7Amin D, Cornell S, Gustafson S, et al. Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis [J]. Lipid Res, 1992,33(11) :1657-1663.
9Little DG, Peat RA, Mcevoy A, et al. Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats [J]. J Bone Miner Res,2003,18(11):2016-2022.
10Astrand J, Aspenberg P. Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats [J]. BMC Musculoskelet Dis ord,2002,3(11) :19.
二级参考文献22
1Marx RE.Pamidronate(Aredia)and zoledronate(Zometa) induced avascular necrosis of the jaws:a growing epidemic.J Oral Maxillofac Surg,2003.61:1115-1118.
2Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws,American Association of Oral and Maxillofacial Surgeons.American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosia of the jaws.J Oral Maxiilofac Surg,2007,65:369-376.
3Mariotti A.Bisphosphonatcs and osteonecrosis of the jaws.J Dent Educ,2008,72:919-929.
4Abu-Id MH,Warnke PH,Gottschalk J,et al."Bis-phossy jaws":high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.J Craniomaxillofac Surg,2008,36:95-103.
5Durie BGM,Katz M,Crowley J.Osteonecrosis of the jaw and bisphosphonates.N Engl J Med,2005,353:99-100.
6Khosla S,Burr D,Canley J,et al.Bispbosphonate-asseciated osteonecrosis of the jaw:report of a task force of the American Society for Bone and Mineral Research.J Bone Mineral Res,2007,22:1479-1491.
7Yarom N,Yahalom R,Shosbani Y,et al.Osteonecrosis of the jaw induced by orally administered bisphosphonates:incidence,clinical features,predisposing factors and treatment outcome.Osteopores Int,2007,18:1363-1370.
8Black DM,Delmas PD,Eastell R,et al.Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.N Engl J Med,2007,356:1809-1822.
9Grbic JT,Landesberg R,Lin SQ,et al.Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.J Am Dent Assoc,2008,139:32-40.
10Lyles KW,Colon-Emetic CS,Magaziner JS,et al.Zoledronic acid and clinical fractures and mortality after hip fracture.N Engl J Med,2007,357:1799-1809.
2Ficarra G, Beninati F. Bisphosphonate-related osteonecrosis of the laws:an update on clinical, pathological and management aspects [J]. Head Neck Pathol, 2007,1(2) :132-140.
3Ruggiem SL, Dodson TB, Assael LA, et al. American association of oral and maxillofacial surgeons position paper on bisphosphonate- related osteonecmsis of the jaws-2009 update[ J. J Ora MaxiUofac Surg, 2009,67(5) :2-12.
4Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) in- duced avascular necrosis of the jaws: a growing epidemiC:[ J]. J Ora Maxillofac Surg, 2003,61 (9) :1115-1117.
5Saia G, Blandamura S, Bettini G, et al, Occurrence of bisphos- phonate-related osteonecrosis of the jaw after surgical tooth, extrac- tion[ J]. J Ora Maxillofac Surg, 2010,68 (4) :797-804.
6Saldanha S, Shenoy VK, Eachampati P, et al. Dental implications of bisphophonate-related osteonecrosis [ J ]. Gerodontology, 2012, 29(3) :177-187.
7Bade1 T, Pavicin IS, Carek AJ, et al. Pathophysiology of osteone- crosis of the jaw in patients treated with bisphosphonate [ J ]. Coll Antropol, 2013,37(2) :645-651.
8Ruggiero SL. Diagnosis and Staging of Medication-Related Osteo- necrosis of the Jaw [ J ]. Oral Maxillofac Surg Clin North Am, 2015,27 (4) :479-487.
9Reich W, Bilkenroth U, Schubert J, et al. Surgical treatment of bisphosphonate-associated osteonecrosis: Prognostic score and long- term results [ J]. J Craniomaxillofac Surg, 2015,43 ( 9 ) : 1809- 1822.
10Ruggiem SL, Dodson TB, Fantasia J, et al. American association of oral and maxillofacial surgeons position paper on medication-re- lated osteonecmsis of the jaw-2014 update [ J]. J Ora Maxillofac Surg, 2014,72 ( 10 ) : 1938-1956.
